Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 1 day agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 1 day agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 12 hours agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 19 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace· 3 hours agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 23 hours agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 2 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...